# FDA Inspection 1281844 - Temple University Medical IRB, #1 & #2 - September 05, 2025

Source: https://www.keypedia.com/records/fda_inspections/temple-university-medical-irb-1-2/eb74c809-1d11-4bf7-ae3c-3e5515574a81
Source feed: FDA_Inspections

> FDA inspection 1281844 of Temple University Medical IRB, #1 & #2, September 05, 2025. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1281844
- Company Name: Temple University Medical IRB, #1 & #2
- Inspection Date: 2025-09-05
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1117477 - 2020-01-27
- FDA Inspection 893981 - 2014-09-04
- FDA Inspection 564561 - 2009-02-10

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/bernardica-t-sculac-stern/44ff2730-4410-4b72-819c-4b90e8904f33)

Company: https://www.keypedia.com/companies/temple-university-medical-irb-1-2/6699936a-bb73-40c2-8dea-3c5be6c86b51

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c